WallStSmart

DarioHealth Corp (DRIO)vsHinge Health, Inc. (HNGE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Hinge Health, Inc. generates 2950% more annual revenue ($646.34M vs $21.19M). HNGE leads profitability with a -78.9% profit margin vs -192.2%. HNGE earns a higher WallStSmart Score of 36/100 (F).

DRIO

Avoid

26

out of 100

Grade: F

Growth: 2.7Profit: 4.0Value: 6.7Quality: 5.5
Piotroski: 3/9Altman Z: -5.45

HNGE

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 3.5Value: 5.0Quality: 5.0
Piotroski: 3/9Altman Z: -2.69
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DRIOUndervalued (+33.2%)

Margin of Safety

+33.2%

Fair Value

$16.47

Current Price

$7.50

$8.97 discount

UndervaluedFair: $16.47Overvalued

Intrinsic value data unavailable for HNGE.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DRIO2 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Return on EquityProfitability
100.5%10/10

Every $100 of equity generates 101 in profit

HNGE2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
47.2%10/10

Revenue surging 47.2% year-over-year

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Areas to Watch

DRIO4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$50.67M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-17.3%2/10

Revenue declined 17.3%

HNGE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
43.4x2/10

Trading at 43.4x book value

Return on EquityProfitability
-197.2%2/10

ROE of -197.2% — below average capital efficiency

EPS GrowthGrowth
-68.4%2/10

Earnings declined 68.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : DRIO

The strongest argument for DRIO centers on Price/Book, Return on Equity.

Bull Case : HNGE

The strongest argument for HNGE centers on Revenue Growth, Debt/Equity. Revenue growth of 47.2% demonstrates continued momentum.

Bear Case : DRIO

The primary concerns for DRIO are EPS Growth, Market Cap, Piotroski F-Score.

Bear Case : HNGE

The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.

Key Dynamics to Monitor

DRIO profiles as a turnaround stock while HNGE is a hypergrowth play — different risk/reward profiles.

HNGE is growing revenue faster at 47.2% — sustainability is the question.

HNGE generates stronger free cash flow (43M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HNGE scores higher overall (36/100 vs 26/100) and 47.2% revenue growth. DRIO offers better value entry with a 33.2% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DarioHealth Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

DarioHealth Corp. The company is headquartered in New York, New York.

Visit Website →

Hinge Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Visit Website →

Want to dig deeper into these stocks?